3
Announcements
Trials
Browse
Landscape
Status
Terminated
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
CNS
1
Conditions
Multiple Myeloma
2
Spondylolisthesis
1
Spinal Stenosis
1
Spinal Cord Neoplasms
1
Smoldering Multiple Myeloma
1
Lymphoma, Follicular
1
Intervertebral Disc Displacement
1
Intervertebral Disc Degeneration
1
Failed Back Surgery Syndrome
1
Interventions
etoposide phosphate
1
Transplantation, Homologous
1
Transplantation, Autologous
1
Therapeutics
1
Temozolomide
1
Radiotherapy
1
RRx-001
1
Patient Discharge
1
Microarray Analysis
1
Irinotecan
1
Immunohistochemistry
1
Ifosfamide
1
Dexamethasone
1
Dasatinib
1
Carboplatin
1
Calcium Dobesilate
1
Bone Transplantation
1
Blotting, Western
1
3-(4-((4-chlorophenyl)sulfonyl)-4-(2,5-difluorophenyl)cyclohexyl)propanoic acid
1
2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Spinal Cord Neoplasms
×
Transplantation, Autologous
×
Clear all
NCT00974623
2017-04-05
APPROACH-001
Baxter Healthcare Corporation
Terminated
329 enrolled